N	Concordance
1	 hypothesis that transfusion-associated immunomodulation affects minimal residua
2	ctions may induce clinically beneficial immunomodulation. Initial clinical trial
3	ditional sensitization, and conditional immunomodulation to understanding MCS. A
4	DPP IV may represent a novel target for immunomodulation in organ transplantatio
5	mice during routine screening tests for immunomodulation. In a retrospective ass
6	l role of endogenous corticosteroids in immunomodulation is poorly understood. T
7	gents. Reports that transfusion-induced immunomodulation decreases survival of c
8	able to test two human pancreatic islet immunomodulation techniques on an in vit
9	e show for the first time seed-specific immunomodulation and the resulting switc
10	supports a role for nitric oxide in the immunomodulation of allogeneic responses
11	ment-resistant disease. The response to immunomodulation and the recent finding